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Abstract
Many disease-susceptible SNPs exhibit significant disparity in ancestral and derived allele frequencies across worldwide
populations. While previous studies have examined population differentiation of alleles at specific SNPs, global ethnic
patterns of ensembles of disease risk alleles across human diseases are unexamined. To examine these patterns, we
manually curated ethnic disease association data from 5,065 papers on human genetic studies representing 1,495 diseases,
recording the precise risk alleles and their measured population frequencies and estimated effect sizes. We systematically
compared the population frequencies of cross-ethnic risk alleles for each disease across 1,397 individuals from 11 HapMap
populations, 1,064 individuals from 53 HGDP populations, and 49 individuals with whole-genome sequences from 10
populations. Type 2 diabetes (T2D) demonstrated extreme directional differentiation of risk allele frequencies across human
populations, compared with null distributions of European-frequency matched control genomic alleles and risk alleles for
other diseases. Most T2D risk alleles share a consistent pattern of decreasing frequencies along human migration into East
Asia. Furthermore, we show that these patterns contribute to disparities in predicted genetic risk across 1,397 HapMap
individuals, T2D genetic risk being consistently higher for individuals in the African populations and lower in the Asian
populations, irrespective of the ethnicity considered in the initial discovery of risk alleles. We observed a similar pattern in
the distribution of T2D Genetic Risk Scores, which are associated with an increased risk of developing diabetes in the
Diabetes Prevention Program cohort, for the same individuals. This disparity may be attributable to the promotion of energy
storage and usage appropriate to environments and inconsistent energy intake. Our results indicate that the differential
frequencies of T2D risk alleles may contribute to the observed disparity in T2D incidence rates across ethnic populations.
Citation: Chen R, Corona E, Sikora M, Dudley JT, Morgan AA, et al. (2012) Type 2 Diabetes Risk Alleles Demonstrate Extreme Directional Differentiation among
Human Populations, Compared to Other Diseases. PLoS Genet 8(4): e1002621. doi:10.1371/journal.pgen.1002621
Editor: Scott M. Williams, Vanderbilt University School of Medicine, United States of America
Received August 11, 2011; Accepted February 9, 2012; Published April 12, 2012
Copyright:  2012 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: RC, EC, JTD, AAM, and AJB were funded by the Lucile Packard Foundation for Children’s Health, the Hewlett Packard Foundation, the National Institute
of General Medical Sciences (R01 GM079719), the National Library of Medicine (R01 LM009719), and the Howard Hughes Medical Institute. JTD was supported by
the National Library of Medicine Biomedical Informatics Training Grant to Stanford University (T15 LM007033). EC was funded by a National Science Foundation
Graduate Research Fellowship and the Armin and Linda Miller Fellowship Fund. MS was funded by the National Institute of Mental Health (R01 MH084695). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: abutte@stanford.edu
¤ Current address: Personalis, Palo Alto, California, United States of America
Introduction
The global rise in incidence of type 2 diabetes (T2D) has been
called a pandemic, and is now commonly identified as a major
international health concern [1]. Although environmental factors
play a substantial role in the etiology of T2D, genetic susceptibility
has been established as a key component of risk [2,3]. However,
the potential disparities in genetic risks for T2D and other major
diseases across different ethnic groups and subpopulations are
poorly characterized. In this study, we evaluate the hypothesis that
disparities in global patterns of T2D risk allele frequencies
contribute to disparities in genetic risk of T2D across diverse
global populations, compared with genomic background and other
diseases.
We evaluate this hypothesis using three catalogs of genetic
variation sampled from diverse ethnic populations [4,5] and
published associations between genetic variants and disease traits
[6]. Specifically, we include 1,397 individuals from 11 populations
represented in the HapMap project [4] and to follow-up findings,
we added 1,064 individuals from 53 indigenous populations across
the world in the Human Genome Diversity Panel (HGDP) [7].
Additionally, we recently sequenced and publically released the
whole genomes of 49 individuals from 10 diverse populations.
Disease associated variants were collated from the thousands of
genetic variants associated with increased disease risk through
thousands of genome-wide and candidate association studies [8],
leveraging our previous efforts to catalog, summarize, and
integrate these risk variants across hundreds of human diseases [6].
PLoS Genetics | www.plosgenetics.org 1 April 2012 | Volume 8 | Issue 4 | e1002621Enabled by the catalogs described above, a recent analysis
demonstrated wide variations in the frequencies of some disease-
susceptible risk alleles across 11 HapMap subpopulations [9], but
with the caveat that many of the well-known disease SNPs were
discovered in population of European ancestry [10]. To further
explore the association between individual genetic risks in
subpopulations, we propose conducting a systematic evaluation
of the differentiation of the risk allele frequencies (RAFs) and
individual genetic risks across population groups. The results aim
to further elucidate the role of ethnicity in clinical diagnosis of
genetic disease risk and also provide guidance towards discovering
additional disease-susceptible genetic variants from diverse
population groups.
We are focusing on T2D and its comparison with other diseases
because of its pandemic prevalence and a striking feature of
extreme population differentiation we find in this study.
Inconsistent results have been previously reported on the
population differentiation of RAF and genetic risk of T2D [11–
15]. However, to our knowledge, most of the studies have been
focused on individual SNPs, and none of them considered the
consistency of directions of population differentiation across all
T2D-susceptible risk alleles. Furthermore, none of these previous
studies have systematically compared the population differentia-
tion between T2D and other diseases.
In this study, we systematically calculate the directional
population differentiation of RAFs across cross-ethnic T2D risk
alleles using genotyping data from diverse population groups in
both HapMap and HGDP, and evaluate the statistical significance
of differentiation against genomic background and other diseases.
We then calculate the predicted genetic risk (PGR) of 1,397
individuals from 11 HapMap populations, and identify diseases
with significant differentiation across diverse population groups.
Results
Each of 12 cross-ethnic T2D SNPs share the same risk
allele and similar odds ratios in 34 studied populations
We manually curated thousands of papers covering human
disease genetics and identified independent risk alleles increasing
the risk of Type 2 diabetes (T2D) across diverse population groups
using the following procedure. Specifically, we curated 50,730
SNPs associating with 1,495 human diseases from 5,065 papers,
and built a quantitative human disease-SNP association database,
called VARiant-INforming MEDicine (Varimed) [6]. Of these,
8,377 SNPs for 437 diseases had been initially reported with a p-
value,10
26, and only these SNPs were used in this study. From
120 T2D SNPs reported in 295 studies in 132 papers with p-
value,10
26, we identified cross-ethnic SNPs as being replicated in
five or more different populations. We then removed SNPs that
are in linkage disequilibrium (R
2.0.7) in Caucasian population in
HapMap (merged HapMap 2+3) [4]. Unless otherwise specified,
HapMap were referred to this merged version throughout this
study. In total, we identified 12 independent cross-ethnic risk
alleles increasing T2D risk, including one in SLC30A8, IGF2BP2,
KCNJ11, FTO, and two in TCF7L2 (R
2=0.512), two in CDKAL1
(R
2=0.677), two in KCNQ1 (R
2=0.425), and two outside gene
regions. All 12 SNPs had been validated to associate with T2D
with p,5610
28 in two or more diverse populations, except
rs11196205 (Table S1). Previous independent reviews and meta-
analysis also support the notion that these 12 SNPs are likely to be
generally relevant to T2D across populations [16–19].
For each of these 12 SNPs, we found that the same allele had
been consistently identified as the risk allele with similar odds
ratios across 34 studied populations (Figure S1, Table S2), though
three SNPs show high heterogeneity of allelic odds ratios between
studies (I
2.75%) and three SNPs show moderate heterogeneity
(I
2.50%) (Table S3). To evaluate whether the shared risk allele
and effect sizes were caused by the bias towards cross-ethnic SNPs,
we identified a second set of replicated T2D SNPs as those that
were replicated in two independent papers with p,5610
28
without the requirement of five or more studied populations. We
identified 11 independent replicated T2D SNPs, including 10
cross-ethnic SNPs and rs864745 in JAZF1. Each of these 11
replicated T2D SNPs shared the same risk allele and similar effect
sizes across all studied populations, suggesting that they are the
best representatives of the causal alleles based on the current data.
T2D risk alleles share a similar pattern of frequency
distribution across 11 HapMap populations
We then plotted the RAF across 11 HapMap populations at
independent cross-ethnic T2D SNPs and evaluated their signifi-
cance of population differentiation against frequency-matched
control genomic alleles. Two risk alleles, including rs5219 in
KCNJ11 and rs2074196 in KCNQ1, were not analyzed due to the
lack of frequency data. Most of remaining ten cross-ethnic T2D
risk alleles shared a similar pattern showing the highest RAF in
African populations and the lowest RAF in Asian populations
(Figure 1). To evaluate the significance of differentiation, we
retrieved all genomic alleles that shared the same European
frequencies and calculated how many of those had both higher
African frequencies and lower Asian frequencies than what we
observed at each risk allele. Seven out of ten SNPs showed larger
differentiation of RAF than 95% European frequency-matched
control genomic alleles (Figure 1). Interestingly, none of the
protective alleles of these ten SNPs exhibited significantly higher
frequencies in the African population groups.
Decreasing RAF from Sub-Saharan Africa to East Asia
regions at cross-ethnic T2D SNPs in HGDP individuals
We then calculated T2D RAF in 53 indigenous populations
from 1,064 individuals in the Human Genome Diversity Panel
(HGDP) [20]. One risk allele, rs5219 in KCNJ11 was not analyzed
due to the lack of frequency data. Nine out of the remaining 11
T2D SNPs exhibited larger differentiation of RAF than 95%
European frequency-matched control genomic alleles, except for
two SNPs in CDKAL1 (Six SNPs in Figure 2, five SNPs in Figure
S2). There is a clear pattern of gradually decreasing RAF from the
Author Summary
We identified 12 risk alleles that had been validated to
increase the risk of type 2 diabetes (T2D) in five or more
differentsubpopulations.Theseriskallelesshare aconsistent
pattern of decreasing frequencies in the human genomes
from Sub-Saharan Africa and through Europe to East Asia
regions. These differential frequencies are statistically
significant, compared with European frequency-matched
control genomic alleles and risk alleles for other diseases.
The differential frequencies of T2D risk alleles further caused
the significant differentiation of genetic risks of T2D, with
higher risk in the African and lower risk in the Asian
populations. The differences might be caused by the
promotion of energy storage and usage appropriate to
environments and inconsistent energy intake. Future
evolutionary and environmental analysis of this unique
pattern may provide further insight on the origin of T2D and
modern disparities in T2D incidence.
Population Differentiation of T2D Risk Alleles
PLoS Genetics | www.plosgenetics.org 2 April 2012 | Volume 8 | Issue 4 | e1002621Figure 1. T2D risk alleles share a similar pattern of frequencies across 11 HapMap populations with higher frequencies in African
and lower frequencies in Asian populations. Risk-allele frequencies (RAF) were shown as heights of bars across the 11 HapMap populations at
10 independent cross-ethnic T2D SNPs, which had been replicated to associate with T2D in five or more diverse populations. Two cross-ethnic T2D
SNPs including rs5219 and rs2074196 were not shown due to the lack of RAF data. Most T2D SNPs share the same pattern of population
differentiation with higher RAFs in the African (ASW, MKK, LWK, YRI, colored in grey and listed on the right) and lower RAFs in the Asian populations
(JPT, CHB, CHD, shaded and listed on the left), compared to the RAFs in the European populations. For each risk allele, a p value was calculated as the
percentage of genomic alleles with matched frequencies in the European populations that show both higher African RAF and lower Asian RAF than
the observed. For example, only 8.96610
25 matched genomic alleles show both higher frequencies in the African populations and lower frequencies
in the Asian populations than the observed frequencies of rs11196205. All T2D risk alleles except for two alleles in CDKAL1 show statistically
significantly larger population differentiation than European frequency-matched genome alleles (p,0.05). The (anc) in the sub-title indicates that the
risk allele is the ancestral allele according to mammalian sequence data, retrieved from dbSNP.
doi:10.1371/journal.pgen.1002621.g001
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PLoS Genetics | www.plosgenetics.org 3 April 2012 | Volume 8 | Issue 4 | e1002621Figure 2. HGDP data show that T2D risk allele frequencies decrease from Sub-Saharan Africa through Europe to East Asia. The
frequencies of six cross-ethnic T2D risk alleles were shown as dark blue wedges across the 53 populations, calculated from 1,064 individuals in the
Human Genome Diversity Panel (HGDP) [7]. All T2D risk alleles decrease frequencies gradually from Sub-Saharan Africa through Europe to East Asia. A
similar pattern was observed in the remaining five T2D risk alleles in Figure S2. The central map shows the Sub-Saharan Africa region on the lower left
and the East Asia region on the right. The smaller map shows Mexico and South America regions. Similar to Figure 1, p values were calculated as the
percentage of genomic alleles with matched frequencies in the European populations that show both higher frequencies in the Sub-Saharan Africa
regions and lower frequencies in the East Asia regions than the observed RAF. All T2D SNPs except for two in CDKAL1 show statistically significantly
larger population differentiation than the frequency-matched genomic alleles (p,0.05). The (anc) in the sub-title indicates that the risk allele is the
ancestral allele according to mammalian sequence data, retrieved from dbSNP.
doi:10.1371/journal.pgen.1002621.g002
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which was shared among all T2D SNPs.
Higher FST values at T2D SNPs than frequency matched
control genomic SNPs
To evaluate whether the observed allele frequency differences
among continental groups for T2D SNPs are unusually high, we
calculated FST as a measure of population differentiation [21].
Specifically, for each of ten cross-ethnic SNPs (rs5219 and
rs2074196 were not analyzed due to the lack of frequency data),
we calculated a global as well as three pairwise FST values by
pooling populations for each of the three major geographic
regions: Africa, Europe, and East Asia. We then compared them
to the genome-wide distribution for allele frequency matched
SNPs (defined as within the same 5% minor allele frequency bin in
the pooled European samples). Consistent with previous results
[12,13], we found that all T2D SNPs showed elevated FST values,
with five out of ten T2D SNPs among the top 10%, and one of
them (rs11196205 in TCF7L2) among the top 1% of the empirical
distribution for at least one of the four population comparisons
(Figure S3). Overall, FST values were significantly higher in T2D
SNPs than the frequency matched genomic SNPs in global FST
(p=0.0057), using a Mann-Whitney U test. Of the pairwise
comparisons, FST of both African vs. East Asian (p=0.0041) and
East Asian vs. European (p=0.025) were also highly significant,
whereas African vs. European was not (p=0.3). Thus, FST values
also support our findings of extreme population differentiation at
T2D SNPs.
T2D risk alleles as an ensemble showed significantly
larger differentiation than other diseases using a novel
directional population differentiation method
FST has been widely used to evaluate population differentiation;
however, it does not take into account whether risk alleles share
the same direction of population differentiation. Here, we
developed a novel directional population differentiation method
by comparing the average increased frequencies across all T2D
risk alleles against the null distribution of European frequency-
matched control genomic alleles. We randomly drew 10 genomic
alleles that share similar frequencies with the T2D risk alleles in
the European populations. Then we calculated their average
increased frequencies in the African compared with European
populations, which is defined as RAFAfrican2RAFEuropean. Re-
peating the process 10,000 times, we got a null distribution of
increased frequencies between African and European populations.
T2D risk alleles as an ensemble demonstrated significantly higher
RAF in the HapMap African populations against the null
distribution of control genomic alleles with a two-side p value of
1.4610
22 (Figure 3B). We adopted the two-side p value to make
our method applicable to any new disease without any prior
knowledge on whether RAFAfrican2RAFEuropean is larger or
smaller than 0. T2D risk alleles as an ensemble showed
significantly higher RAF in the populations in the Sub-Saharan
Africa regions (p=4.9610
22, Figure 3D), and significantly lower
RAF in the East Asia regions (p=1.0610
24, Figure 3C),
compared to control genomic alleles. We also observed very
similar results when analyzing the directional population differen-
tiation using a single T2D SNP from each gene.
We then evaluated whether this increased RAF in the Sub-
Saharan Africa regions was significant against risk alleles from
hundreds of other diseases. As a background, we extracted 15,649
risk alleles that had previously been reported as significantly
associated with 975 human diseases from Varimed [6]. We
randomly drew 11 risk alleles which share similar frequencies with
T2D risk alleles in the European populations and calculated a null
distribution of increased frequencies. We found that T2D risk
alleles showed significantly higher RAF in the Sub-Saharan Africa
region than risk alleles from other diseases (Figure 3D, p=0.05).
Similarly, we found that T2D risk alleles showed significantly
lower RAF in the HapMap Asia (p=8.5610
23, Figure 3A) and
HGDP East Asia regions (p=4.0610
24, Figure 3C). Therefore,
our novel method demonstrated that T2D risk alleles as an
ensemble showed significantly larger population differentiation
than frequency-matched control genomic alleles and risk alleles
from hundreds of other diseases.
We used this method to systematically evaluate the directional
differentiation of RAF of cross-ethnic risk alleles for all diseases in
Varimed. We identified 12 common diseases that contain five or
more independent cross-ethnic risk alleles (CEU R
2,0.7); each of
which had been known to associate with the disease with
p,1610
26 and be replicated in five or more different populations
(Materials and Methods). T2D was the only disease that showed
significantly decreased RAF in the East Asian populations
(p=1610
24, Figure 4) and significantly increased RAF in the
Sub-Saharan African populations (p=4.9610
22, Figure 5), com-
pared with frequencies in the European populations. Prostate
cancer showed relatively increased RAF in the Sub-Saharan
African populations (p=6.4610
22, Figure 5), without decreased
RAF in the East Asian populations ((p=0.61, Figure 4). We
repeated the study using disease-susceptible risk alleles that had
been replicated in two independent papers with p,5610
28, and
got very similar results (Figures S4, S5, S6). One small difference is
that prostate cancer showed significantly higher RAF in the Sub-
Saharan African populations at replicated risk alleles (p=4610
23,
Figure S6). Therefore, T2D risk alleles showed the most extreme
differentiation of RAF across human populations, compared with
other diseases.
Interestingly, ensembles of obesity-susceptible risk alleles did not
show significant differentiation of RAF in either East Asian
(p=0.37, Figure 4) or Sub-Saharan African populations (p=0.79,
Figure 5). Eight out of 12 independent cross-ethnic obesity-
susceptible risk alleles did not show significantly larger differen-
tiation of RAF than control genomic alleles, individually (Figure
S7). Among the remaining four risk alleles, two are located within
FTO and known to increase the risk of T2D as well. Therefore, we
did not observe any consistent pattern of RAF across obesity-
susceptible risk alleles. The decoupling between obesity- and T2D-
susceptible risk alleles indicates that their evolutionary histories are
likely different.
T2D showed the most significant population
differentiation on Predicted Genetic Risk (PGR) among 40
diseases
Having shown the extreme differentiation of frequencies across
T2D risk alleles, we further combined the effect size from all
independent risk variants to systematically evaluate the differen-
tiation of genetic risk of T2D and 39 other diseases. Using a
method we had previously developed [22,23], we calculated a
Predicted Genetic Risk (PGR) of 40 diseases for each of 1,397
individuals using 1.46 million SNPs genotyped in the HapMap
release 3 (HapMap3). We only used the HapMap3 data to
calculate the PGR so that the same set of SNPs was used for each
individual. For each disease, we identified risk SNPs that have
been validated in five or more populations, estimated their
increased Likelihood Ratio (LR) using the genotype frequencies in
the case/control groups reported in each previous study, and
finally combined the LRs from multiple SNPs using ethnic-specific
Population Differentiation of T2D Risk Alleles
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2 data to report a summarized risk score
for each disease. The summarized score estimates the Predicted
Genetic Risk (PGR) for an individual given their genotypes at
independent risk SNPs.
We calculated the PGR for each of 1,397 individuals on 40
diseases (Table S5), and found that seven diseases showed
significantly larger population differentiation than global frequen-
cy-matched genomic SNPs (Figure 6). After Benjamini-Hochberg
multi-test correction, only T2D and colorectal cancer demon-
strated significantly larger population differentiation than random
genomic SNPs. After accounting for the genomic SNPs, T2D
showed significantly increased PGR in the African populations
relative to others (p=4.7610
23), and significantly decreased PGR
in the Asian populations relative to others (p=3.0610
25).
Colorectal cancer showed a similar pattern, but the PGR
differences among population groups were much smaller because
Figure 3. An ensemble of T2D risk alleles demonstrates significant directional differentiation of frequencies among human
populations, compared to genomic control alleles and risk alleles for other diseases. Eleven independent cross-ethnic T2D risk alleles
were combined as an ensemble to calculate the average increased frequencies in the populations in Asia (A) and Africa (B) from HapMap, and the
East Asia (C) and Sub-Saharan Africa (D) from HGDP, compared with the frequencies in the European populations. The average increased RAFs of T2D
risk alleles are shown as dotted vertical lines, and compared against the null distributions of average increased RAFs of 11 alleles randomly drawn
from genomic alleles (solid black curve) and disease-susceptible risk alleles (dashed grey curve) that share the same allele frequencies with T2D risk
alleles in the European populations. Two-side p values were calculated by comparing dotted vertical lines against the null distributions of frequency-
matched control genomic alleles and risk alleles of other diseases. SNPs used in each figure were summarized in Table S4.
doi:10.1371/journal.pgen.1002621.g003
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of observed PGR differences was estimated using a genomic
background by randomly selecting global frequency-matched
genomic SNPs and re-calculating the PGR on each disease using
the random SNPs. We then calculated the likelihood of observing
a larger PGR difference between each of three population groups
(Asian, European, African) and others. Overall, T2D demonstrat-
ed the most significant population differentiation on PGR
compared to frequency-matched genomic SNPs.
Consistent pattern of T2D PGR using ethnic-specific
SNPs, validated risk scores, and different genotyping/
sequencing technologies
Finally, we evaluated the robustness of the observed ethnic
disparity of T2D PGR in three conditions. To evaluate the effect of
SNPs discovered and validated in specific subpopulations, we
compared the distributions of PGR using only the ethnicity-specific
T2D SNPs, their genotype frequencies in the case and control
groups, and LR separately from studies specifically on each of the
Figure 4. Differential risk allele frequencies in the East Asian populations for 12 common diseases, compared with the frequencies
in the European. We identified 12 common diseases with five or more independent cross-ethnic risk alleles from Varimed. Similar with Figure 3, we
plotted the average increased RAFs in the East Asia regions in the HGDP for each of 12 diseases, against the null distributions of frequency-matched
control genomic alleles and risk alleles for other diseases. We ordered these 12 diseases by the increased RAF for a direct comparison. T2D was the
only disease showing significantly lower RAFs in the East Asian populations. Two-side p values were calculated by comparing dotted vertical lines
against the null distributions of frequency-matched control genomic alleles and risk alleles of other diseases. SNPs used in each figure were
summarized in Table S4.
doi:10.1371/journal.pgen.1002621.g004
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Indian Asian (Figure 7). T2D PGR distributions demonstrated a
strikingly similar pattern no matter which original studies were used
toretrievethepreviouslydiscovered significant T2D SNPs, genotype
frequencies, and LRs. African populations always have the highest
PGR and Asian populations always have the lowest PGR.
Recently, a T2D genetic risk score had been validated to
associate with the increased risk of developing diabetes in a
prospective random trial on 2,843 Diabetes Prevention Program
participants from five ethnic groups representative of the U.S.
population [19]. The T2D genetic risk score was calculated by
multiplying the number of risk alleles by the natural log of the odds
ratio at each SNP, and summing over 34 SNPs. Twenty SNPs
were measured in the HapMap3 individuals. We calculated the
T2D risk score for each of 1,397 HapMap3 individuals, and found
the same differential T2D genetic risks, with significantly increased
risk in the African populations (p=0.01) and significantly
decreased risk in the Asian populations (p=3.5610
23, Figure 8).
Third, in each of the studies above, we were constrained in the
number of SNPs usable for calculating PGR for T2D, based on
Figure 5. Differential risk allele frequencies in the Sub-Saharan African populations for 12 common diseases, compared with the
frequencies in the European. Similar with Figure 4, we plotted the average increased RAFs in the Sub-Saharan Africa regions in the HGDP for each
of 12 diseases, against the null distributions of frequency-matched control genomic alleles and risk alleles for other diseases. We ordered these 12
diseases by the increased RAF for a direct comparison. T2D shows significantly increased RAFs in the Sub-Saharan African populations, followed by
prostate cancer. Two-side p values were calculated by comparing dotted vertical lines against the null distributions of frequency-matched control
genomic alleles and risk alleles of other diseases. SNPs used in each figure were summarized in Table S4.
doi:10.1371/journal.pgen.1002621.g005
Population Differentiation of T2D Risk Alleles
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the set of SNPs genotyped in individuals in HapMap3 and HGDP.
To ensure our findings are not an artifact of bias in the measured
SNPs, we repeated our analysis using a larger set of T2D
associated SNPs in 49 individuals for which whole genome
sequencing is obtained, including 4 JPT, 4 CHB, 5 MEX, 3 Puerto
Rican, 2 TSI, 14 CEU, 5 ASW, 1 MKK, 4 LWK, and 7 YRI. The
subpopulation distributions of PGR were very similar between
whole genome sequencing and genotyping technologies (Hap-
Map3) for T2D (Figure 9). This equality did not hold for all
diseases, as very different distributions are observed for melanoma.
This suggests that current genotyping technology captures enough
Figure 6. Seven diseases show significantly differential genetic risks across 11 HapMap populations, compared to frequency-
matched control genomic genotypes. The density plots were drawn for the histograms of log(PGR) values with different colors and line styles
representing each of 11 different HapMap3 populations. PGR represents Predicted Genetic Risk (PGR) with higher risk on the right. Seven diseases
showed significantly differential PGR across populations, including type 2 diabetes (A), colorectal cancer (B), cleft palate (C), type 1 diabetes (D),
prostate cancer (E), Parkinson’s disease (F), and lung cancer (G). p_Afr shows the likelihood of observing lager log(PGR, African)-log(PGR, Other) values
after randomly replacing disease genotypes with global frequency-matched genomic genotypes. For example, an average value of log(PGR) is 0.648
in African populations and 20.224 in other populations for T2D. After randomly replacing T2D genotypes with control genomic genotypes, there is
only 4.7610
23 chance finding an average value of log(PGR, African)-log(PGR, Other) larger than 0.872. Similarly, p_Asi and p_Eur represent the
likelihoods of observing more extreme values of log(PGR, Asian)-log(PGR, Other) and log(PGR, European)-log(PGR, others) using randomly selected
genomic genotypes, respectively. All p values were calculated as two-sided p values. SNPs used in each figure are summarized in Table S4.
doi:10.1371/journal.pgen.1002621.g006
Population Differentiation of T2D Risk Alleles
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diseases, such as T2D, while whole genome sequencing will likely
capture many more genetic variants influencing melanoma and
perhaps other diseases.
Discussion
We developed a novel method to systematically evaluate the
directional differentiation of Risk Allele Frequencies (RAF) of
ensembles of cross-ethnic SNPs for 12 common diseases across 11
populations from the HapMap project and 53 indigenous
populations from the HGDP project. We found that type 2
diabetes (T2D) demonstrated the significant differentiation of RAF
among diverse populations, compared with the European
frequency-matched control genomic alleles and risk alleles for
other diseases (Figure 3, Figure S4). T2D showed the most
extreme differentiation among 12 common diseases, no matter
whether we used cross-ethnic SNPs that had been replicated in five
Figure 7. A consistent pattern of T2D PGR using SNPs and LRs from ethnic-specific studies. The density plots were drawn for the
histograms of log(PGR) values across 11 HapMap3 population groups using T2D SNPs and likelihood ratios (LRs) from previous studies specifically on
each of the following ethnicities: Caucasian (A), African (B), Chinese (C), Japanese (D), and Indian Asian (E). Eleven HapMap3 population groups are
plotted with solid or dashed lines with different colors. PGR presents Predicted Genetic Risk with higher risk on the right. A consistent pattern was
observed with the highest PGR in the African populations (LWK, YRI, ASW, MKK) and the lowest PGR in the Asian populations (JPT, CHD, CHB)
regardless which ethnic-specific T2D SNPs and LRs were used. p_Asi, p_Eur, and p_Afr represent the likelihoods of observing more extreme values of
log(PGR, Asian)-log(PGR, Other), log(PGR, European)-log(PGR, others), and log(PGR, African)-log(PGR, Other) using randomly selected control genomic
genotypes, respectively. All p values were calculated as two-sided p values. SNPs used in each figure are summarized in Table S4.
doi:10.1371/journal.pgen.1002621.g007
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replicated in two studies (Figures S5, S6). This extreme
differentiation is caused by the phenomenon that all T2D risk
alleles share a consistent pattern of gradually decreasing
population frequencies from Sub-Saharan Africa through Europe
to East Asia regions (Figure 1, Figure 2, Figure S2).
This phenomenon, that T2D risk alleles decrease frequencies
when humans migrate [24], suggests many potential explanations.
One likely cause is the adaptation to the disparities of agriculture
development across continents. It has been previously reported
that some T2D SNPs have higher risk allele frequencies in
populations where cereals are the main dietary component, and
observed risk allele frequency might be related to historical events,
such as the dispersal out of Sub-Saharan Africa to regions with
different climates and the adoption of more specialized-often less
diverse-diets (i.e. farming and animal husbandry vs. foraging) [25].
There were three major events in human evolution, including
early migration from 200KYA to 10KYA, agriculture revolution
and population expansion from 10KYA to 4KYA, and new world
discovery and associated mass-migration and admixture after
4KYA [26]. The significantly decreased frequencies of T2D risk
alleles in the East Asia might be caused by the agriculture
revolution, including the cultivation of white rice and pork in
China. A related explanation stems from the thrifty genotype [27]
hypothesis, which asserts that a predisposition to insulin resistance
may have protected individuals during periods of food deprivation
by reducing muscle utilization of glucose and favoring glucose
utilization in organs, such as brain, that operates through an
insulin independent mechanism [27]. Combining these two related
explanations together, we speculate that the decreasing T2D risk
allele frequencies are caused by the promotion of energy storage
and usage appropriate to environments and insistent energy
intakes.
Another speculation is that T2D is known to find roots in the
mismatch between our genetics and environment, as food
contributes a significant environmental impact. When humans
migrate, environmental change may have led to a mismatch
between genetics and available diet, and put a positive
evolutionary pressure on the frequencies of T2D protective alleles.
Therefore, the decreasing T2D risk alleles are expected, while the
other diseases are unusual given the underlying demographic
history. Future evolutionary analysis on these T2D SNPs may
provide some insight on the origin of this pandemic disease, as will
more population-specific genetic studies.
Having shown the extreme differentiation of T2D RAF, we
further combined the effect sizes from all independent risk variants
and calculated a Predicted Genetic Risk (PGR) for each of 1,397
individuals in the HapMap3 project. T2D showed the most
significant population differentiation among 40 diseases, after
correcting for control genomic genotypes (Figure 6). We identified
a consistent pattern of high PGR in the African and low PGR in
the Asian regardless whether we used ethnic-specific SNPs
(Figure 7), validated risk scores (Figure 8), or different genotyp-
ing/sequencing technologies (Figure 9). Our results indicate that
there is indeed a differential T2D genetic risk across different
populations across continents. The distributions we have found are
very similar to a recent report measuring 19 common variants on
five continent populations [15], with the highest risk in the African
populations, and lowest risk in the East Asian populations.
The populations examined by this study are distributed broadly
around the world, representing a wide range of environmental
exposures and lifestyles. Hence, it is challenging to associate the
increased prevalence of risk-associated alleles with actual mani-
festations of T2D, which we know to be heavily influenced by
environmental factors. However, studies in England and the
United States have consistently shown that individuals with
African ancestry have increased diabetes rates relative to their
neighbors of European or East Asian ancestry [28–31], while those
with Chinese ancestry had lower incidence compared to others in
a recent 10-year Canadian study [32]. At the same time, citizens in
China have higher prevalence of T2D within their own country
[33,34]. Disparities in T2D rates may be attributed to social,
cultural, and economic differences or possible genetic confounders
such as admixing of ancestral ethnicities, though our results
suggest that differential genetics may indeed play some role in
these differences in incidence rates.
We also found that African had higher PGR on prostate cancer
than other populations. Epidemiology data from Center for
Disease Control and Prevention from 1999 to 2007 show that
incidence of prostate cancer is 1.56 times higher in the African
American than white American. Further investigation on the
genetic reasons behind the observed ethnic disparity of disease
incidence rates across ethnic/racial groups might identify
personalized medicine to improve the health disparity.
Many challenges to evaluate the population differentiation of
RAF and PGR remain. Foremost, many of the SNPs identified
from genome-wide association studies (GWASs) are tag SNPs and
are therefore not assumed to be causal [35]. However, each of the
12 cross-ethnic T2D SNP share the same risk allele and similar
effect sizes across 34 different studied populations (Figure S1,
Table S2), suggesting that they are the best representatives of the
causal alleles based on the current data. The consistent
observation of differential T2D genetic risk with different SNPs,
Figure 8. Distribution of T2D Genetic Risk Scores in 1,397
HapMap3 individuals. A high T2D Genetic Risk Score (GRS) had been
previously shown to significantly associate with increased risk of
developing diabetes in participants from Diabetes Prevention Program
[19]. We calculated the GRS scores for 1,397 individuals using 20 SNPs
measured in the HapMap and plotted the distribution of GRS across 11
HapMap populations. The distribution of GRS is very similar with that of
PGR in Figure 6A. p_Asi, p_Eur, and p_Afr represent the likelihoods of
observing more extreme values of log(GRS, Asian)-log(GRS, Other),
log(GRS, European)-log(GRS, others), and log(GRS, African)-log(GRS,
Other) using randomly selected control genomic genotypes, respec-
tively. All p values were calculated as two-sided p values. GRS SNPs
were summarized in Table S4.
doi:10.1371/journal.pgen.1002621.g008
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variants are identified, but this remains a hypothesis that needs to
be tested in the future. Second, we acknowledge that we adopted a
relaxed p value cutoff of p,1610
26 to identify cross-ethnic SNPs
for a wide-variety of diseases for comparisons. With more GWAS
in diverse population groups, a more rigorous cutoff and ethnicity-
specific effects should be used. Third, there may be some ethnic-
specific gene-environment interaction. Forth, our observed
disparity of PGR between population groups might be related to
the disparities in the application of modern genetic tools to study
diseases across ethnicities. Finally, a large component of heritable
risk is still missing for most common diseases, and consequently
missing in our analysis here [36]. Future GWAS and sequencing
studies on different ethnic groups under diversified environmental
conditions will likely further reveal and illustrate the origins of
complex diseases.
In conclusion, we found that T2D risk alleles demonstrated
extreme differentiation compared to other diseases, with popula-
tion frequencies decreasing from Sub-Saharan Africa and through
Europe to East Asia. These patterns may contribute to the
observed disparity of T2D incidence rates across worldwide ethnic
populations.
Figure 9. Comparison of PGR distributions between whole-genome sequencing and genotyping technologies. The ethnic distributions
of log(PGR) of T2D and Melanoma were calculated for 49 individuals sequenced with over 556coverage by Complete Genomics and 1,397 HapMap3
individuals genotyped on Illumina 1M and Affymetrix 6.0 arrays. Similar differential T2D genetic risks were observed between two technologies, while
differential melanoma genetic risk was only observed from whole genome sequencing. SNPs used in each figure were summarized in Table S4.
doi:10.1371/journal.pgen.1002621.g009
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VARiant Informing MEDicine (Varimed): A quantitative
disease–SNP association database
As described previously [6], we have been manually curating a
quantitative human disease-SNP association database from litera-
ture. First, we downloaded all abstracts from MEDLINE, and
identified human genetic papers using a list of Medical Subject
Headings [37], such as ‘‘Genome-Wide Association Study’’,
‘‘Genetic Variation’’, ‘‘Polymorphism, Genetic’’, ‘‘Genome, Hu-
man’’, ‘‘Polymorphism, Single Nucleotide’’, ‘‘Genotype’’, ‘‘Genetic
Predisposition to Disease’’, ‘‘Case-Control Studies’’, ‘‘Alleles’’,
‘‘Cohort Studies’’. We then filtered these papers through abstracts,
titles, and keywords. We also downloaded papers from curated
disease-SNP databases, such as GWAS catalog from National
Human Genome Research Institute [38]. Combined together, we
identified 5,065 human genetic papers representing 1,495 diseases.
Second, four curators manually extracted data from the full text,
figures, tables, and supplemental materials of 5,065 human genetics
papers, and recorded more than 100 features from each paper. We
recorded many aspects of the associations, including the disease
name (e.g. coronary artery disease), specific phenotype (e.g. acute
coronary syndrome in coronary artery disease), study population
(e.g. Finnish individuals), case and control population (e.g. 2,508
patients with coronary artery disease proven by angiography),
gender distribution, genotyping technology, major/minor/risk
alleles, odds ratio, 95% confidence interval of the odds ratio,
published p value, and genetic model. Studies on similar diseases
were categorized and mapped to the Concept Unique Identifiers
(CUI) from the Unified Medical Language System (UMLS) [39].
For each study, the frequencies of each genotype and allele in the
case and control populations were recorded, and used to estimate
the effect size [22,23].
Systematically identify independent cross-ethnic and
replicated risk alleles for 12 diseases
We identified all disease-susceptible alleles from Varimed that
were reported to increase the risk of human disease with p-
value,10
26. We focused on alleles that were directly associated
with the increased risk of human disease by removing the following
SNPs: SNPs that were specified as non-significant in the original
papers, SNPs that were identified from studies with diseased
patients in the control groups, SNPs that were associated with non-
disease traits, SNPs that were associated with disease through
haplotype blocks or interaction terms. Risk alleles on the negative
strands were translated into alleles in the positive strands. Negative
strands were identified by comparing the major/minor alleles in
the study with the major/minor alleles in the similar population in
the HapMap3. Many risk alleles had been reported in multiple
studies, and we integrated all studies and ranked the risk alleles by
the strength of replication, including the number of replicated
populations, studies, and total sample sizes.
We identified cross-ethnic SNPs as SNPs being associated with a
disease with a p-value,1610
26 in at least one populations and
reported as significant in five or more different subpopulations
with a p-value,1610
26 in GWAS studies or p-value,0.01 in
small candidate studies. We removed SNPs that were specified as
non-significant in the original papers. For each disease, we ranked
all cross-ethnic SNPs by the number of replication studies, the total
sample sizes and the number of populations where the associations
being replicated. Starting from risk alleles with the strongest
evidence, we identified risk alleles with the linkage disequilibrium
R
2$0.7 in the CEU population in the HapMap project, and
removed ones with less evidence. We identified 12 diseases with 5
or more independent cross-ethnic risk alleles, each of them being
validated in five or more populations. We found 12 independent
cross-ethnic risk alleles for Type 2 diabetes (T2D), and plotted
their association p values across 34 populations using the levelplot
function in R. We then evaluated the between-study heterogeneity
of allelic odds ratios on each of 12 cross-ethnic T2D SNPs using
the meta R package. Similarly, we identified disease SNPs that
have been replicated in two or more papers with p,5610
28.
Evaluate the population differentiation of RAF against
European frequency-matched control genomic alleles at
individual disease-susceptible SNP
We retrieved the allele frequencies at 2.3 million SNPs in the 11
populations from HapMap 2+3, which were released in August
2010. We plotted the RAFs across the 11 populations as bar
graphs at each independent cross-ethnic risk allele for each disease
using a barplot function in R.
We then evaluated the statistical significance of the population
differentiation of RAF at each disease SNP by calculating the
percentage of European frequency-matched control genomic
alleles that show the RAF difference larger than the observed.
For each risk allele, we retrieved all control genomic alleles sharing
similar average frequencies within 60.01 in the European (TSI,
CEU) populations. Then, we calculated the percentage of matched
genomic alleles that have both African frequencies higher than the
observed and Asian frequencies lower than the observed. We
recorded the percentage as a p value which is the likelihood of
finding similar or larger differentiation of RAF from frequency-
matched genomic alleles. All risk alleles with p,0.05 were
considered as showing significantly larger population differentia-
tion than control genomic alleles.
We received the measured and imputed allele frequencies at 3.1
million SNPs across 53 populations from 1,064 individuals from
Human Genome Diversity Panel (HGDP) from Joseph Pickrell
from University of Chicago [7,13]. We modified a script from
Joseph Pickrell using Generic Mapping Tools [40] and plotted the
worldwide map showing the distribution of RAF across the 53
HGDP populations [13]. Similar with the analysis on HapMap,
we calculated the percentages of European frequency-matched
genome alleles that have both Sub-Saharan African frequencies
higher than the observed and East Asian frequencies lower than
the observed.
We categorized populations into three major regions. Sub-
Saharan Africa region includes BantuSouthAfrica, Biaka Pygmies,
Mandenka, Mbuti Pygmies, San, Yoruba, and BantuKenya. East
Asia region includes Cambodian, Dai, Daur, Han, Han-NChina,
Hezhen, Japanese, Lahu, Miao, Mongola, Naxi, Oroqen, She, Tu,
Tujia, Uygur, Xibo, Yakut, and Yi. Europe region includes Adygei,
Basque,French,Italian,Orcadian,Russian,Sardinian,and Tuscan.
Compare FST values of T2D SNPs against those of control
genomic SNPs
Global FST, as well as three pairwise FST (African vs. East Asian,
African vs. European, East Asian vs. European) values were
calculated for all SNPs from HapMap3, using a custom script
implementing the method in the PopGen module of BioPerl [41].
For the calculations, all populations for the respective geographic
regions were pooled, so that the global FST reflected the overall
differentiation of those major geographic regions. All SNPs were
grouped into 10 bins according to their average Minor Allele
Frequencies (MAF) across the European HapMap3 populations
(CEU, TSI), and T2D SNPs were compared to all genomic SNPs
within the same MAF bin. For the Mann-Whitney U test, we used
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mean and dividing by the standard deviation within each MAF bin
for each SNP.
Systematically evaluate directional population
differentiation of ensembles of independent cross-ethnic
risk alleles for 12 diseases
We evaluated the population differentiation of an ensemble of
10 independent cross-ethnic T2D risk alleles by comparing their
average increased RAF in the African populations against the null
distribution of control genomic alleles and 15,649 risk alleles from
975 diseases. First, we randomly retrieved 10 control genomic
alleles that share similar European frequencies (60.05) with T2D
risk alleles, and calculated their average increased frequencies in
the African populations (MKK, LWK, YRI, ASW). Repeating the
above process 10,000 times, we drew a null distribution of
increased frequencies between African and European populations
from control genomic alleles. The average increased frequency of
10 T2D risk alleles in the African vs. European populations was
then compared with the null distribution to calculate the likelihood
of observing consistently increased African frequencies from
matched genomic alleles.
Similarly, we randomly retrieved 10 European frequency-
matched alleles (60.05) from 15,649 risk alleles from other diseases,
and calculated a null distribution of increased African frequencies
from disease risk alleles. We also calculated the null distribution of
Asian frequencies from HapMap, East Asian and Sub-Saharan
African frequencies from HGDP using European frequency-
matched genomic alleles and risk alleles from other diseases.
Calculate the distribution of PGR across the 11 HapMap3
population groups
Using a method we described previously [22,23], we calculated
the Predicted Genetic Risk (PGR) of 40 diseases for 1,397
individuals from HapMap release 3. Each individual was genotyped
at 1.46 million SNPs. We calculated the PGR of 40 diseases using
independent cross-ethnic SNPs, each of them had been validated in
five or more different populations. We estimated a genetic risk using
a likelihood ratio for each SNP defined by the relative frequency of
an individual’s genotype in the diseased vs. healthy control
populations (e.g., given a genotype ‘‘AA’’, LR=Pr(AA|diseased)/
Pr(AA|control)). The LR incorporated both the sensitivity and
specificity of the test and provided a direct estimate of how much a
test result would change the odds of having a disease [23]. We
excluded studies with diseased patients in the control group. For
eachallele,we averaged theLRsfrom multiple studies with a weight
of the square root of the sample size to give higher confidence to
studies with larger sample size. For SNP pairs in linkage
disequilibrium (R
2$0.3 in the corresponding population group),
we removed the SNP with weaker evidence according to the
number of replication studies, sample sizes and validated popula-
tions. We considered remaining SNPs as independent genetic test
and multiplied their LRs to report the summarized score as the
PGR. We then plotted the distribution of PGR across 11 HapMap
populations using a kernel density function in the R package.
Evaluate the statistical significance of population
differentiation of PGR against control genomic SNPs
To evaluate the statistical significance of the population
differentiation of PGR after correcting the difference of RAF, we
randomly replaced disease genotypes with global frequency-
matched non-associated genotypes, and re-calculated the PGR for
each of 1,397 HapMap individuals. We calculated the PGR using
the random control genomic genotypes along with the original LR,
averaged the log(PGR) values for each of 11 population groups, and
repeated the process 100,000 times. Then we calculated the p_Afr
as the percentage of obtaining a value of log(PGR, African)-
log(PGR, Other) from random genotypes larger than the observed
values. Similarly, we calculatedp_Asi and P_Eurasthelikelihoodof
obtaining more extreme values of log(PGR, Asian)-log(PGR, Other)
and log(PGR, European)-log(PGR, Other) from random genomic
genotypes. Each p value was calculated as a two-side p value.
Calculate the distribution of PGR using SNPs and LRs
from ethnic-specific studies
We recalculated the distribution of PGR across the 11 HapMap
populations using SNPs and LRs that were associated with T2D
with p,1610
26 in the original studies on each of the following
populations, including Caucasian, African, Chinese, Japanese, and
Indian Asian.
Whole-genome sequences of 49 individuals from 10
population groups
Whole-genome sequences were produced using published
methods [42] for 49 cell-line derived DNA samples obtained from
the Coriell Institute. Each genome was sequenced to over 556
coverage and calls were produced using a local de novo assembly
based pipeline. Comparison of these data to dbSNP was performed
using alignment-based methods which account for SNPs which may
be contained within more complex variant sequences.
We pooled the 49 samples into three groups: Asian, African, and
Others. Then we calculated the distribution of PGR across these
three population groups on T2D and Melanoma. All disease SNPs
with p,1610
26 in the original studies on any ethnicity were used.
Supporting Information
Figure S1 Each of 12 cross-ethnic T2D SNPs shares the same risk
allele and similar odds ratio in 34 studied populations. The heatmap
graph summarizes the odds ratios across 34 studied populations at 12
independent cross-ethnic T2D SNPs. Each row represents a T2D
SNP replicated in five or more populations. For example,
7903146_T_TCF7L2 represents a T risk allele at rs7903146 in
TCF7L2. All odds ratios are larger than 1 with the risk allele listed at
the left. For any SNP pairs with linkage disequilibrium R
2$0.7 in
HapMap Caucasian, only the SNP with stronger evidence is kept.
Two SNPs are considered as independent in TCF7L2, CDKAL1,a n d
KCNQ1 because their R
2s are 0.512, 0.677, and 0.425 respectively.
Detailed evidence including PubMed and p values in each population
is shown in Table S2. Meta-analysis indicates that the study group
consists of at least two populations from distinct population groups,
such as East Asian, European, African, Mexican, and Indian Asian.
(PDF)
Figure S2 HGDP data show that T2D risk alleles decrease
frequencies from Sub-Saharan Africa to East Asia (five SNPs not
listed in Figure 2). Risk allele frequencies (RAF) are shown as dark
blue wedges across the 53 HGDP populations at five T2D SNPs
that are not listed in Figure 2. The frequencies of protective allele
are shown as orange wedges. For each T2D risk allele, a p value was
calculated as the percentage of genomic alleles with matched
frequencies in European populations that showed both higher
frequencies in the Sub-Saharan Africa regions and lower frequen-
ciesintheEastAsia regionsthan the observedRAF.The(anc)inthe
sub-title indicates that the risk allele is the ancestral allele according
to mammalian sequence data, retrieved from the dbSNP.
(PDF)
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matched control genomic SNPs in HapMap3. For each multiethnic
T2DSNP, global andthree pairwise(African vs.EastAsian, African
vs. Europe, East Asian vs. Europe) FST values were calculated and
compared with the FST distribution of genomic SNPs that were
within the same 5% European minor allele frequency (MAF) bins.
Rank percentiles are shown for T2D SNPs against MAF matched
genomic SNPs. All T2D SNPs show elevated FST values, with five
out of ten T2D SNPs among 10% and 1 (rs11196205 in TCF7L2)
among the top 1% of the empirical distribution for at least one of
four population comparisons. P values were calculated to compare
the FST values of T2D SNPs against frequency matched genomic
SNPs, and listed at the top (Mann-Whitney U test).
(PDF)
Figure S4 Directional population differentiation of RAF for
T2D SNPs replicated in two papers. Eleven independent SNPs
had been replicated to associate with T2D with p,5610
28 in two
distinct papers. Ten of them had been measured in the HapMap
project, except rs5219. They were combined as an ensemble to
calculate the average increased RAFs in the Asia (A) and Africa (B)
populations from HapMap, and the East Asia (C) and Sub-
Saharan Africa (D) populations from HGDP, compared with the
RAFs in the European populations. The average increased RAFs
of T2D risk alleles are shown as dotted vertical lines, compared
against the null distributions of average increased RAFs of 10
alleles randomly drawn from genomic alleles (solid black curve)
and disease-susceptible risk alleles (dashed grey curve) that share
the same allele frequencies with T2D risk alleles in the European
populations. Two-side p values were calculated by comparing
dotted vertical lines against the null distributions of frequency-
matched genomic alleles and disease-susceptible risk alleles. SNPs
used in each figure are summarized in Table S4.
(PDF)
Figure S5 Differential RAF in the East Asian versus European
populations at replicated SNPs for 12 common diseases. For each
of 12 diseases, we identified SNPs that had been replicated for
association with p,5610
28 in two distinct papers. We calculated
their average increased RAF (dotted vertical line) in the East Asian
versus European populations in HGDP, compared with the null
distributions of European-frequency-matched control genomic
alleles (solid density plot) and risk alleles for other diseases (dotted
density plot). These 12 diseases were ordered by the increased
RAF in the East Asian populations. T2D is the only disease
showing significantly lower RAF in the East Asian populations.
SNPs used in each figure were summarized in Table S4.
(PDF)
Figure S6 Differential RAF in the Sub-Saharan African versus
European populations at replicated SNPs for 12 common diseases.
For each of 12 diseases, we identified SNPs that had been replicated
for association with p,5610
28 in two distinct papers. We calculated
their average increased RAF (dotted vertical line) in the Sub-Saharan
African versus European populations in HGDP, compared with the
null distributions of European-frequency-matched genomic control
alleles (solid density plot) and risk alleles for other diseases (dotted
density plot). These 12 diseases were ordered by the increased RAF in
the Sub-Saharan African populations. Prostate cancer and T2D
shows significantly increased RAFs in the Sub-Saharan African
populations. SNPs used in each figure were summarized in Table S4.
(PDF)
Figure S7 RAF of Obesity risk alleles across the 11 HapMap
populations. The frequencies of 11 independent multiethnic
Obesity risk alleles are shown as heights of bars across the 11
HapMap populations. RAFs in the Asian populations (JPT, CHB,
CHD) are shaded and listed on the left. RAFs in the African
populations (ASW, MKK, LWK, YRI) are colored in grey and
listed on the right. Higher RAFs in the African and lower RAFs in
the Asian populations are only observed in 2 SNPs in FTO and 2
SNPs outside the gene region, including rs29941 and rs925946.
Two SNPs in FTO are shared genetic risk variants with T2D. No
consistent patterns are observed across obesity-specific risk alleles.
The (anc) in the sub-title indicates that the risk allele is the
ancestral allele from mammalian data, retrieved from the dbSNP.
(PDF)
Table S1 Significance of T2D association and replication of the
12 cross-ethnic SNPs.
(PDF)
Table S2 Associations of 12 independent cross-ethnic T2D
SNPs across 34 populations.
(PDF)
Table S3 Between-study heterogeneity analysis of allelic Odds
Ratios on T2D risk alleles.
(PDF)
Table S4 Summary of disease-susceptible SNPs used in the
figures.
(PDF)
Table S5 Statistical significance of ethnic disparity of PGR
across 11 HapMap3 populations on 40 diseases.
(PDF)
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